Lantheus to Acquire Evergreen Theragnostics for up to $1 Billion

New York – January 28, 2025 – Cooley advised Lantheus Holdings (Nasdaq: LNTH), a radiopharmaceutical-focused company committed to enabling clinicians to find, fight and follow disease to deliver better patient outcomes, on its definitive agreement to acquire Evergreen Theragnostics. Under the terms of the agreement, Lantheus will pay an upfront amount of $250 million in cash at closing and up to $752.5 million in development and sales milestones related to OCTEVY, a registrational-stage diagnostic imaging agent, and Evergreen’s clinical and preclinical pipeline. The transaction has been approved by the boards of directors of both companies and is expected to close in the second half of 2025, subject to customary closing conditions, including regulatory clearances.

Lawyers Bill Roegge, Div Gupta, Geoffrey Spolyar, Zachary Sonenshine and Sarah Buchik led the Cooley team advising Lantheus.

Cooley previously advised Lantheus on its concurrent private investment in public equity (PIPE) transaction, partnering transaction and asset sale with Perspective Therapeutics in January 2024.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation.

Cooley has nearly 1,400 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of more than 3,000 people.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.